FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship between HER2 and the transcription factor FoxM1 in breast cancer. HER2 and Fox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Francis, Richard E., Myatt, Stephen S., Krol, Janna, Hartman, Johan, Peck, Barrie, McGovern, Ursula B., Wang, Jun, Guest, Stephanie K., Filipovic, Aleksandra, Gojis, Ondrej, Palmieri, Carlo, Peston, David, Shousha, Sami, Yu, Qunyan, Sicinski, Piotr, Coombes, R. Charles, Lam, Eric W.-F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065068/
https://ncbi.nlm.nih.gov/pubmed/19513552
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados